HT is diagnosed based on the elevated levels of circulating antibodies against thyroid antigens: thyroperoxidase (TPO) and thyroglobulin (Tg), and is supported by the decreased thyroid echogenicity on ultrasound (22). The gene discussed is TPO; the disease is hematocrit.